Business Context and Reporting Period
This Form 6-K filing by Can-Fite Biopharma Ltd. covers the month of April 2021, specifically dated April 23, 2021. The filing serves to announce the Company's Annual General Meeting of Shareholders scheduled for May 31, 2021, at 3:00 p.m. Israel time at its principal executive offices in Petach Tikva, Israel.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural notice regarding shareholder meetings and does not contain financial statements or performance data.
Material Changes
No material changes to financial performance or operations are reported in this filing. The document focuses solely on the administrative logistics of the upcoming Annual General Meeting.
Guidance, Outlook, and Management Commentary
There is no financial guidance, outlook, or management commentary regarding business strategy or risks included in this filing. The document provides details on voting procedures, including the availability of proxy cards for ordinary share holders and voting instruction cards for American Depositary Share holders.
Key Facts for Investor Verification
- Meeting Date: Annual General Meeting is set for May 31, 2021.
- Meeting Location: 10 Bareket Street, Petach Tikva, Israel.
- Voting Materials: Notice and Proxy Statement (Exhibit 99.1), Proxy Card for ordinary shares (Exhibit 99.2), and Voting Instruction Card for ADS holders (Exhibit 99.3) are attached.
- Financial Data: Investors should refer to the Company's Form 20-F or other periodic reports for financial metrics, as none are present in this filing.